WINTON GROUP Ltd Makes New $12.24 Million Investment in Merit Medical Systems, Inc. $MMSI

WINTON GROUP Ltd acquired a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 138,856 shares of the medical instruments supplier’s stock, valued at approximately $12,239,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL bought a new position in Merit Medical Systems during the 3rd quarter worth $2,913,050,000. State Street Corp boosted its position in shares of Merit Medical Systems by 1.1% during the 2nd quarter. State Street Corp now owns 2,218,432 shares of the medical instruments supplier’s stock worth $207,379,000 after acquiring an additional 24,569 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after acquiring an additional 980,823 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Merit Medical Systems by 6.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,177,862 shares of the medical instruments supplier’s stock worth $98,021,000 after acquiring an additional 68,711 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Merit Medical Systems by 20.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 948,079 shares of the medical instruments supplier’s stock worth $83,564,000 after acquiring an additional 158,723 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Insider Buying and Selling

In related news, insider Brian G. Lloyd bought 2,000 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the completion of the transaction, the insider directly owned 2,000 shares of the company’s stock, valued at approximately $125,240. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lynne N. Ward sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the sale, the director owned 7,809 shares in the company, valued at $488,921.49. This represents a 39.04% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Merit Medical Systems Stock Performance

Shares of Merit Medical Systems stock opened at $64.48 on Friday. Merit Medical Systems, Inc. has a fifty-two week low of $59.74 and a fifty-two week high of $96.74. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. The firm has a market capitalization of $3.85 billion, a P/E ratio of 27.91, a P/E/G ratio of 1.96 and a beta of 0.54. The company’s 50 day moving average price is $65.76 and its two-hundred day moving average price is $76.06.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same quarter last year, the business posted $0.86 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities analysts forecast that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on MMSI shares. JPMorgan Chase & Co. reduced their price target on shares of Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Needham & Company LLC reduced their price target on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Compass Point set a $107.00 price target on shares of Merit Medical Systems in a research report on Monday, April 20th. BTIG Research started coverage on shares of Merit Medical Systems in a research report on Friday, February 6th. They set a “buy” rating and a $107.00 price target on the stock. Finally, Robert W. Baird set a $83.00 price target on shares of Merit Medical Systems in a research report on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $92.80.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.